Abstract:Background Thromboembolism (TE) is a complication in pediatric patients with congenital heart disease (CHD) due to disrupted blood flow, inflammation, foreign materials and cardiac surgery. Reported rates of TE in pediatric patients with CHD vary. Furthermore, most studies report TE rates following cardiac surgery, but there is a scarcity of data describing TE rates prior to cardiac surgery, the timing of these events, as well as the rates of post-operative TE recurrence in this population Given the limited information available describing the incidence and timing of TE both before and after cardiac surgery, the primary aim of this study was to describe the rate of TE 12 months before and 12 months after cardiac surgery in pediatric pts with CHD. Methods This was a single center retrospective study from October 2020 to June 2023 (inclusive). Patients were eligible for inclusion if they were <18 years of age, underwent cardiac surgery for congenital heart disease, and had a radiologic confirmed diagnosis of a thrombus either 12 months before or 12 months after CHD surgery. Data collection was conducted using the institution's surgical database and through electronic medical record chart review. Variables included age (neonates: <28 days of age, infants: 1 month to <12 months of age, children: 1 year to <12 years of age, and adolescents: 12 to 18 years of age), surgical procedure, administration of prothrombin complex concentrate, thrombotic history, cardiac catheterization ≤30 days of TE, lines at time of TE, treatment agents, and TE recurrence rates. Data analysis was conducted using descriptive statistics. Results A total of 260 children underwent cardiac surgery during the study period, of these, 36 patients (14%) had a TE and were eligible for inclusion. Four patients had 2 operations during the study period for a total of 40 surgical encounters. The majority of patients were neonates and infants (85%) at the time of cardiac surgery (Table 1). Of the 36 (patients who had a TE, 6 (16.7%) patients had a TE prior to cardiac surgery, 23 (63.9%) had a TE after cardiac surgery, and 7 (19.4%) had a TE both before and after cardiac surgery. The median (range) time of TE occurring prior to or after cardiac surgery was 86 (2-277) days and 17 (1-335) days, respectively. Thromboembolism types included: 8 (22.2%) patients with arterial, 25 (69.4%) with venous, and 3 (8.3%) patients with both arterial and venous. Of note, 11 (20.5%) patients who developed thromboembolism had a history of prior TE >12 months prior to surgery. Twenty-four (62.5%) patients received prothrombin complex concentrate intra-op, and 16 (44.4%) patients had cardiac catheterization 30 days prior to the documented TE (Table 1). With regards to lines, 75% of TE were associated with a central venous/arterial catheter (Table 2). Treatment agents in the acute period included: no agent (6, 16.6%), unfractionated heparin (5, 13.9%), enoxaparin (21, 58.3%), bivalirudin (2, 5.6%), and new/increased antiplatelet therapy (2, 5.6%). Treatment agents in the subacute period included: no agent (10, 27.8%), enoxaparin (17, 47.2%), bivalirudin (2, 5.6%), unfractionated heparin (1, 2.8%), rivaroxaban (2, 5.6%), and new/increased antiplatelet therapy (4, 11.1%%). Overall median (range) duration of treatment was 49 (3-182) days. Of the 36 patients, 8 (21.2%) patients had at least 1 recurrent thromboembolism (Table 2). Conclusions We report in this single center retrospective study a high incidence of TE in children with CHD not only after cardiac surgery but also prior to surgery. Awareness of TE prior to cardiac surgery may be beneficial for optimizing post-operative prevention strategies to minimize the recurrence of TE. Future multicenter prospective studies are needed to validate these findings and evaluate risks factors for TE in pediatric patients with CHD both before and after cardiac surgery.

Anesthetic Management for Aspiration Thrombectomy Using the Penumbra Indigo System in Pediatric Patients with Congenital Heart Disease

Penumbra Indigo® system to safely remove intracardiac thrombus in a 7-month-old infant with severe immunodeficiency disorder

Anesthetic management in patients having catheter-based thrombectomy for acute pulmonary embolism: A narrative review

Anesthetic management for percutaneous reverse Potts shunt creation in children with refractory idiopathic pulmonary arterial hypertension: A case series

Endovascular Therapy in Pediatric Stroke: Utilization, Patient Characteristics, and Outcomes

A single institution anesthetic experience with catheterization of pediatric pulmonary hypertension patients

Postoperative catheter thrombaspiration to open an occluded right ventricle-to-pulmonary artery conduit in child

Anesthetic management of a child with double outlet right ventricle and severe polycythemia: A case report

Anesthetic management of children with medically refractory pulmonary hypertension undergoing surgical Potts shunt

Thromboelastography-guided Intraoperative Platelet Transfusion in Pediatric Heart Surgery

Perioperative Outcomes of Thrombectomy Patients Using Venovenous Bypass and Suction Filtration With General Anesthesia

Incidence and Timing of Thromboembolism in Pediatric Patients with Congenital Heart Disease Undergoing Cardiac Surgery: A Single Center Retrospective Study

A prospective study of various anesthetic techniques in patients with acyanotic congenital heart diseases undergoing device closure

Anesthetic management of a patient with dilated cardiomyopathy and purpura for interventional thrombectomy of both femoral artery: Case report

Anesthetic Management of a Child From the Qinghai-tibet Plateau With a Double Outlet Right Ventricle and Severe Polycythemia: A Case Report

Anesthetic Management of Thoracoscopic Procedures in Neonates: a Retrospective Analysis of 45 Cases.

Single-center experience with Indigo aspiration thrombectomy for acute lower limb ischemia

Sedation versus General Anesthesia for Cardiac Catheterization in Infants: A Retrospective, Monocentric, Cohort Evaluation

Anesthetic management of a patient with congenital cyanotic heart anomaly for emergency surgery: A case report

Peri-operative Anticoagulation Strategies, Bleeding and Thrombotic Complications in Pediatric Patients Undergoing Intervention for Congenital Portosystemic Shunts

Management of Bleeding and Thrombotic Complications During Pediatric Extracorporeal Membrane Oxygenation: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE Consensus Conference